within Pharmacolibrary.Drugs.ATC.A;

model A05BA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.23,
    Cl             = 0.1325,
    adminDuration  = 600,
    adminMass      = 0.14,
    adminCount     = 1,
    Vd             = 0.0562,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.006166666666666667,
    Tlag           = 9.6
  );

  annotation(Documentation(
    info ="<html><body><p>Silymarin is a standardized extract obtained from the milk thistle plant (Silybum marianum). It is composed primarily of flavonolignans, the most prominent being silibinin. Silymarin is widely used as a hepatoprotective agent to treat chronic liver diseases such as hepatitis, alcoholic liver disease, and to protect the liver from toxins. Although commonly used as an herbal supplement, it is not officially approved as a drug by most regulatory authorities, but is marketed in various countries for liver disorders.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after oral administration of silymarin (standardized to silibinin).</p><h4>References</h4><ol><li><p>Gillessen, A, &amp; Schmidt, HH (2020). Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review. <i>Advances in therapy</i> 37(4) 1279–1301. DOI:<a href=&quot;https://doi.org/10.1007/s12325-020-01251-y&quot;>10.1007/s12325-020-01251-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32065376/&quot;>https://pubmed.ncbi.nlm.nih.gov/32065376</a></p></li><li><p>Han, Y, et al., &amp; Zhou, HH (2009). Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 39(9) 694–699. DOI:<a href=&quot;https://doi.org/10.1080/00498250903060077&quot;>10.1080/00498250903060077</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19555315/&quot;>https://pubmed.ncbi.nlm.nih.gov/19555315</a></p></li><li><p>Fuhr, U, et al., &amp; Mengs, U (2007). The effect of silymarin on oral nifedipine pharmacokinetics. <i>Planta medica</i> 73(14) 1429–1435. DOI:<a href=&quot;https://doi.org/10.1055/s-2007-990256&quot;>10.1055/s-2007-990256</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17968815/&quot;>https://pubmed.ncbi.nlm.nih.gov/17968815</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A05BA03;
